Originally approved to treat type 2 diabetes, this medication has shown remarkable results in helping individuals without diabetes achieve meaningful weight reduction
A consensus report by the American Diabetes Association (ADA) and the European Association for the study of Diabetes (EASD)
Lou Z, Zhu J, Li X, Li X, Du K, Wang B, Zhang F, Zhang X (2021) LncRNA Sirt1-AS upregulates Sirt1 to attenuate aging related deep venous thrombosis
The SELECT trial demonstrated that semaglutide reduces major adverse cardiovascular events by 20% in patients with obesity and established heart disease
And in men while not officially approved it has shown the ability to induce erections and boost libido, offering hope to those for whom traditional ED treatments fall short
Physical Activity and Sleep Exercising can improve sleep quality, so it's important to fit it into your daily routine